Provident Financial Services Inc(PFS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PFS Provident Financial Services Inc

交易中 05-20 12:20:40 EDT

16.07

-0.11

-0.71%

最高16.25	最低15.93	成交量24.78万
今开16.22	昨收16.18	日振幅1.98%
总市值20.88亿	流通市值20.40亿	总股本1.30亿
成交额398.04万	换手率0.20%	流通股本1.27亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PFS","market":"US","secType":"STK","nameCN":"Provident Financial Services Inc","latestPrice":16.065,"timestamp":1716222020581,"preClose":16.18,"halted":0,"volume":247829,"delay":0,"floatShares":127000000,"shares":130000000,"eps":1.599292,"marketStatus":"交易中","marketStatusCode":2,"change":-0.115,"latestTime":"05-20 12:20:40 EDT","open":16.22,"high":16.2525,"low":15.9319,"amount":3980360.503535,"amplitude":0.019815,"askPrice":16.07,"askSize":297,"bidPrice":16.06,"bidSize":270,"shortable":3,"etf":0,"ttmEps":1.599292,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1716235200000},"adr":0,"listingDate":1042693200000,"adjPreClose":16.18,"adrRate":0,"dividendRate":0.059757,"preHourTrading":{"tag":"盘前","latestPrice":16.18,"preClose":16.18,"latestTime":"09:25 EDT","volume":23923,"amount":387074.14,"timestamp":1716211522982},"postHourTrading":{"tag":"盘后","latestPrice":16.12,"preClose":16.18,"latestTime":"17:28 EDT","volume":117470,"amount":1900683.26,"timestamp":1715981313592},"volumeRatio":0.129296},"requestUrl":"/m/hq/s/PFS","defaultTab":"news","newsList":[{"id":"2435311624","title":"奥凯乐® （瑞普替尼）获中国国家药监局批准，用于治疗ROS1阳性非小细胞肺癌患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2435311624","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2435311624?lang=zh_cn&edition=full","pubTime":"2024-05-13 13:59","pubTimestamp":1715579940,"startTime":"0","endTime":"0","summary":"TRIDENT-1研究显示，瑞普替尼针对TKI初治、TKI经治和颅内转移的ROS1阳性非小细胞肺癌患者都具有高缓解率和良好的持久性。2023年5月，瑞普替尼被国家药监局纳入优先审评。中国亚组人群的疗效和安全性数据与全球人群一致，在ROS1阳性非小细胞肺癌患者中表现出稳健的缓解率和持久的临床活性。2023年11月，瑞普替尼获得美国FDA批准，用于治疗ROS1阳性的局部晚期或转移性非小细胞肺癌成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4412272_ZH12272_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429156276","title":"欧盟委员会批准 CARVYKTI®用于复发和难治性多发性骨髓瘤患者的二线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2429156276","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2429156276?lang=zh_cn&edition=full","pubTime":"2024-04-23 14:36","pubTimestamp":1713854160,"startTime":"0","endTime":"0","summary":"BCMA主要表达于恶性多发性骨髓瘤B细胞谱系、晚期B细胞和浆细胞的表面。2022年2月，西达基奥仑赛获得美国FDA批准上市，5月获得欧盟EC授予的附条件上市许可，9月获得日本MHLW批准上市，用于治疗复发或难治性多发性骨髓瘤成人患者，商品名为CARVYKTI。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4394792_ZH94792_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429976927","title":"嗡嗡声--美国股票走势-AZZ、Smartsheet、Zions Bancorporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2429976927","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429976927?lang=zh_cn&edition=full","pubTime":"2024-04-23 00:17","pubTimestamp":1713802632,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      4月22日 - 由于中东紧张局势缓解提振了风险偏好，华尔街主要股指在前一交易日大幅下挫后周一上涨，同时投资者展望本周将有重大科技财报和关键的通胀数据公布。美东时间 中午 12:02，道琼斯工业平均指数  上涨0.31%，报38,103.16点。标准普尔500指数  上涨0.44%，报4,989.16点；纳斯达克综合指数  上涨0.50%，报15,358.854点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429871978","title":"BUZZ-D.A. Davidson 将 Provident Financial 的评级上调至 \"买入 \"后，该公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2429871978","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429871978?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:01","pubTimestamp":1713798119,"startTime":"0","endTime":"0","summary":"    4月22日 - ** 社区银行普罗维登斯金融服务公司  股价最高上涨5.8%，最后上涨5.3%，报15.23美元** D.A.戴维森将PFS的评级从 \"中性 \"上调至 \"买入\"；将目标价从5美元上调至20美元，较上次收盘价上涨38.3%。** 交易最初预计于 2023 年下半年完成，但因等待监管部门批准而推迟** 五家券商中有三家给予该股 \"买入 \"评级，两家给予 \"持有 \"评级；他们的中位预测价格为 19 美元 - LSEG** 截至上次收盘，PFS股价年累计下跌19.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429271924","title":"公积金金融服务盘中异动 早盘急速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429271924","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429271924?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:57","pubTimestamp":1713794233,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时57分，公积金金融服务股票出现波动，股价急速上涨5.03%。截至发稿，该股报15.19美元/股，成交量12.2053万股，换手率0.16%，振幅2.35%。公积金金融服务股票所在的银行行业中，整体涨幅为0.43%。该公司的业务仅限于金融服务行业，包括向客户提供传统银行和其他金融服务。消息层面，截至21时57分，《DA Davidson：上调Provident Finl Servs评级，由中性调整至买入评级, 目标价由15.00美元调整至20.00美元。》资讯为影响公积金金融服务的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222157147922592b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222157147922592b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429923380","title":"DA Davidson：上调Provident Finl Servs(PFS.US)评级，由中性调整至买入评级, 目标价由15.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429923380","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429923380?lang=zh_cn&edition=full","pubTime":"2024-04-22 20:15","pubTimestamp":1713788151,"startTime":"0","endTime":"0","summary":"DA Davidson：上调Provident Finl Servs(PFS.US)评级，由中性调整至买入评级, 目标价由15.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220162587a15b84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220162587a15b84&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428965054","title":"公积金金融服务盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428965054","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428965054?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:04","pubTimestamp":1713535448,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日22时04分，公积金金融服务股票出现异动，股价快速上涨5.01%。截至发稿，该股报14.44美元/股，成交量13.5832万股，换手率0.18%，振幅8.69%。公积金金融服务股票所在的银行行业中，整体涨幅为0.94%。该公司的业务仅限于金融服务行业，包括向客户提供传统银行和其他金融服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192204087a541eb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192204087a541eb6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428686044","title":"Provident Finl Servs(PFS.US)：2024年Q1财报实现营收9367万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428686044","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428686044?lang=zh_cn&edition=full","pubTime":"2024-04-19 14:52","pubTimestamp":1713509548,"startTime":"0","endTime":"0","summary":"Provident Finl Servs(PFS.US)：2024年Q1财报实现营收9367万美元，前值为1.083亿美元，预期值为9295万美元；每股收益为0.43美元，前值为0.54美元，预期值为0.40美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191507208b39c4a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191507208b39c4a3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428353508","title":"骨髓瘤新药开发或迎转折点，一场攻克癌症的预演","url":"https://stock-news.laohu8.com/highlight/detail?id=2428353508","media":"蓝鲸财经","top":-1,"share":"https://www.laohu8.com/m/news/2428353508?lang=zh_cn&edition=full","pubTime":"2024-04-17 10:50","pubTimestamp":1713322203,"startTime":"0","endTime":"0","summary":"4月12日，FDA召开了今年第3场肿瘤咨询委员会讨论会。这不仅意味着，历经多年MRD终获认证，从而有望大幅缩短MM新药的上市时间，对于抗肿瘤新型试验终点的开发和验证，或许也会产生深远的影响。一项在肺癌中开展的研究证明，超过99%的MRD阴性患者没有复发，并且MRD在常规成像之前预测复发。对于MM或其他肿瘤新药研发来说，未来几年，令人兴奋的挑战或许是如何更好地利用MRD来指导临床及治疗决策。这也对MM新药临床终点提出了新的要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/230556","is_publish_highlight":false,"gpt_icon":0},{"id":"2428020208","title":"Provident Financial Services Inc    预计每股收益 40 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2428020208","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428020208?lang=zh_cn&edition=full","pubTime":"2024-04-17 04:02","pubTimestamp":1713297769,"startTime":"0","endTime":"0","summary":"   * Provident Financial Services Inc    将于4月18日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于新泽西州泽西城的公司的营收将从去年同期的1.0832亿美元降至9274.2万美元，降幅为14.4%。* LSEG 分析师对 Provident Financial Services Inc 的平均预期为每股收益 40 美分。* 华尔街对 Provident Financial Services Inc 的 12 个月目标价中位数为 17.00 美元，高于其最新收盘价 14.01 美元。4月16日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426492841","title":"公积金金融服务盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426492841","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426492841?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:39","pubTimestamp":1712756385,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时39分，公积金金融服务股票出现异动，股价急速下跌5.00%。公积金金融服务股票所在的银行行业中，整体跌幅为1.58%。该公司通过其遍布新泽西州北部和中部以及宾夕法尼亚州某些县的分支机构网络提供全面的金融产品和服务。消息层面，截至21时39分，《加拿大皇家银行：维持Provident Finl Servs评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至18.00美元。》资讯为影响公积金金融服务的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213946861e4a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213946861e4a6e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426111392","title":"加拿大皇家银行：维持Provident Finl Servs(PFS.US)评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426111392","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426111392?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:25","pubTimestamp":1712676319,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持Provident Finl Servs(PFS.US)评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092325238b03e9c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092325238b03e9c1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425269640","title":"我国首个肾癌免疫疗法获批，君实生物拓益®为中国患者带来新选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2425269640","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2425269640?lang=zh_cn&edition=full","pubTime":"2024-04-07 15:49","pubTimestamp":1712476140,"startTime":"0","endTime":"0","summary":"据统计，2022年中国肾癌新发病例和死亡病例分别约为7.7万例和4.6万例2。此次特瑞普利单抗新适应症的获批开启了中国晚期肾癌靶免联合的新篇章，将会彻底改写我国晚期肾癌的临床实践，更重要的是能够为中高危患者带来新的治疗选择！特瑞普利单抗联合阿昔替尼疗法的获批填补了中国人群肾癌一线免疫治疗的空白，相较靶向药单药治疗，特瑞普利单抗靶免联合疗法能够显著提升患者的PFS，将为我国广大晚期肾癌患者带来福音。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4381480_ZH81480_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424989421","title":"益普生索马杜林®新适应症在华获批，胃肠胰神经内分泌肿瘤治疗迎来新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2424989421","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2424989421?lang=zh_cn&edition=full","pubTime":"2024-04-03 17:42","pubTimestamp":1712137320,"startTime":"0","endTime":"0","summary":"在2023年公布的中国第二批罕见病目录中，胃肠胰神经内分泌肿瘤被收录其中，进一步提升了公众对于疾病的认知和关注，推动疾病早诊早治，为患者带来更多获益。受益于罕见病药物研发和审评的利好政策，可进行深部皮下自我注射的索马杜林获批用于胃肠胰神经内分泌肿瘤的治疗，为患者提供了更便捷的治疗方案，有效改善患者无进展生存期，助力疾病长程管理，提高患者生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4378838_ZH78838_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422133959","title":"基石药业公布2023年年度业绩及公司近期业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2422133959","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2422133959?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:00","pubTimestamp":1711548000,"startTime":"0","endTime":"0","summary":"2023年总收入为人民币4.638亿元，其中商业化收入人民币3.681亿元。稳健的财务状况，截至2023年12月31日现金储备为10.3亿人民币；年内亏损减少57%。预期两项申请将在2024年陆续获批。苏州2024年3月27日 /美通社/ -- 基石药业，一家专注于研究开发及商业化创新肿瘤免疫疗法及精准治疗药物的领先生物制药公司，今日公布其2023年年度业绩及近期业务亮点。业务摘要 截至2023年12月31日止年度及截至本公告日期，我们的产品管线及业务经营均已取得重大进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4372459_ZH72459_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422958015","title":"安斯泰来 VYLOY™ (zolbetuximab)在日本获批用于治疗胃癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2422958015","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2422958015?lang=zh_cn&edition=full","pubTime":"2024-03-27 15:20","pubTimestamp":1711524000,"startTime":"0","endTime":"0","summary":"VYLOY成为目前世界首个且唯一被批准的CLDN18.2靶向疗法。安斯泰来自豪地为日本这一有紧迫医疗的难治性癌症作出贡献，该地区的发病率在全球范围内居高不下。这些结果支持VYLOY成为日本CLDN18.2阳性患者群体的新治疗选项。2022年仅日本就有近44,000名患者死于胃癌。安斯泰来同时向全球其他监管机构递交了VYLOY的新药上市申请，目前这些申请正在评审阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4372113_ZH72113_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.provident.bank","stockEarnings":[{"period":"1week","weight":0.0202},{"period":"1month","weight":0.188},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0339},{"period":"1year","weight":0.0019},{"period":"ytd","weight":-0.1026}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Provident Financial Services, Inc.是一家特拉华州公司，于2003年1月15日成为Provident Bank的控股公司。该公司通过其子公司银行开展业务，该银行是一家面向社区和客户的银行，目前在新泽西州北部和中部以及宾夕法尼亚州的雄鹿县、利哈伊县和北安普敦县以及纽约州的拿骚县和皇后区经营全方位服务的分行和贷款生产办事处。该银行还通过其全资子公司Beacon Trust Company提供信托和财富管理服务，并通过其全资子公司Provident Protection Plus, Inc.提供保险服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.028736},{"month":2,"riseRate":0.409091,"avgChangeRate":-0.014442},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.001162},{"month":4,"riseRate":0.5,"avgChangeRate":0.008294},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007494},{"month":6,"riseRate":0.47619,"avgChangeRate":-0.002618},{"month":7,"riseRate":0.619048,"avgChangeRate":0.028506},{"month":8,"riseRate":0.47619,"avgChangeRate":-0.011999},{"month":9,"riseRate":0.380952,"avgChangeRate":-0.016518},{"month":10,"riseRate":0.666667,"avgChangeRate":0.037244},{"month":11,"riseRate":0.666667,"avgChangeRate":0.02828},{"month":12,"riseRate":0.571429,"avgChangeRate":0.018079}],"exchange":"NYSE","name":"Provident Financial Services Inc","nameEN":"Provident"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Provident Financial Services Inc(PFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Provident Financial Services Inc(PFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Provident Financial Services Inc,PFS,Provident Financial Services Inc股票,Provident Financial Services Inc股票老虎,Provident Financial Services Inc股票老虎国际,Provident Financial Services Inc行情,Provident Financial Services Inc股票行情,Provident Financial Services Inc股价,Provident Financial Services Inc股市,Provident Financial Services Inc股票价格,Provident Financial Services Inc股票交易,Provident Financial Services Inc股票购买,Provident Financial Services Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Provident Financial Services Inc(PFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Provident Financial Services Inc(PFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}